Updated Dec. 21, 2012 at 11:57 a.m.

Premium Lock GSK news: Partner's stock plunges after trial failure; new vaccine effort underway

Published: 2012-12-21 11:44:00
Updated: 2012-12-21 11:57:58

Print this blog post

GSK, partner Amicus aren't giving up on a treatment for Fabry disease despite failure in a trial. Meanwhile, GSK strikes a partnership with a Swiss firm to tackle new anti-bacterial vaccines....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners


Vivek Wadhwa
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science